Françoise Meunier: Join us at the conference on 15 February 2024 dedicated to ending financial discrimination
Françoise Meunier posted on LinkedIn:
“Participating in the European Cancer Summit and listening to the impactful stories of cancer patients and survivors is truly inspiring. These narratives reinforce my commitment to combating discrimination against cancer survivors. In my presentation, I provided an overview of the current status of right-to-be-forgotten legislation in the EU. While progress is evident, there’s still work to be done to ensure comprehensive protection for all cancer survivors.
Join us at the conference on 15 February 2024 dedicated to ending financial discrimination:”
Source: Françoise Meunier/LinkedIn
Françoise Meunier dedicated her professional life to improving the survival and QoL of cancer patients. Prof. Meunier served as Director-General of the European organization for Research and Treatment of Cancer (1991-2015), where she remained active until 2018 as Director of Special Projects, being the driving force behind cancer survivorship activities. Since 2014, she has been pursuing activities on the Right to be Forgotten for cancer survivors, advocating for the creation of a harmonised legal framework to tackle discrimination against cancer survivors. Prior to joining the EORTC, Françoise Meunier was Head of Infectious Diseases Department at Institute Jules Bordet. Prof. Meunier was awarded the Belgian Laureate Prix Femmes d’Europe 2004-2005, conferred the title of Baroness by His Majesty, King Albert II of Belgium in 2007, received the Pezcoller Foundation award in 2009, became a Fellow of the European Academy of Cancer Sciences in 2011, joined the Scientific Committee of the Innovative Medicine Initiative of the European Union in 2012, received the ECCO Life time achievement award in 2013, awarded a Ben de Pauw Medal for her dedication to Medical Mycology in 2013, appointed council member of the Federation of European Academies of Medicine in 2014, appointed Chair of Accreditation Council of Oncology in Europe and Member of Alliance for Biomedical Research in Europe in 2015, and has been a member of the Belgian Royal Academy of Medicine since 2006.